Avelumab with axitinib for untreated advanced renal cell carcinoma (MA review of TA645)

Hawa, Asyl, Picot, Jo, Woods, Lois, Ribeiro, Ines and Lord, Joanne (2026) Avelumab with axitinib for untreated advanced renal cell carcinoma (MA review of TA645) Southampton Health Technology Assessments Centre 121pp.

Record type: Monograph (Project Report)

Abstract

This report is a critique of the company’s submission (CS) to NICE from Merck on the clinical effectiveness and cost effectiveness of avelumab (Bavencio) in combination with axitinib (Inlyta) for treating adults with untreated advanced renal cell carcinoma (aRCC). It identifies the strengths and weakness of the CS.

Text

Avelumab EAG report - Version of Record

Available under License Creative Commons Attribution.

Download (1MB)

More information

Published date: 8 January 2026

Related URLs:

https://www.nice.org.uk/guidan...5551615053

Identifiers

Local EPrints ID: 508324

URI: http://eprints.soton.ac.uk/id/eprint/508324

PURE UUID: cbe7c38d-fe7d-48fd-ada2-351f9d4550be

ORCID for Asyl Hawa:

orcid.org/0000-0002-2270-1057

ORCID for Jo Picot:

orcid.org/0000-0001-5987-996X

ORCID for Lois Woods:

orcid.org/0000-0002-4587-9149

ORCID for Ines Ribeiro:

orcid.org/0000-0001-8464-4513

ORCID for Joanne Lord:

orcid.org/0000-0003-1086-1624

Catalogue record

Date deposited: 16 Jan 2026 18:39

Last modified: 17 Jan 2026 03:20

Export record

Share this record

Share this on Facebook Share this on Twitter Share this on Weibo

Contributors

Author: Asyl Hawa

Author: Jo Picot

Author: Lois Woods

Author: Ines Ribeiro

Author: Joanne Lord

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Library staff additional information